(PubMed) Heart Protection Study Collaborative Group
With greater government oversight, the compounded peptides will likely be safer than the current, unregulated formulas, Imtiaz said, but they are still not fully FDA-approved medications
doi: 10.1126/scitranslmed.aah4477 Summary Keywords metabolic syndrome, atherosclerotic cardiovascular disease, hypertension, endothelial dysfunction, platelet hyperactivity Citation Das D, Shruthi NR, Banerjee A, Jothimani G, Duttaroy AK and Pathak S (2023) Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies
Herzenberg LA, De Rosa SC, Dubs JG, Roederer M, Anderson MT, Ela SW, Deresinski SC, Herzenberg LA (1997)
First, How Should We Even Judge a Sweetener